• 1
    Felson DT. (1993) Choosing a core set of disease activity measures for rheumatoid arthritis clinical trials. Journal of Rheumatology, 21, 531534.
  • 2
    Kirwan JR. (1992) A theoretical framework for process, outcome and prognosis in rheumatoid arthritis. Journal of Rheumatology, 19, 333336.
  • 3
    Anderson JJ, Felson DT, Meenan RF, Williams HJ. (1989) Which traditional measures should be used in rheumatoid arthritis clinical trials Arthritis and Rheumatism, 32, 10931099.
  • 4
    van Riel PLCM. (1992) Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis. British Journal of Rheumatology, 31, 793794.
  • 5
    Tugwell P., Boers M., For the OMERACT Committee. (1993) OMERACT conference on outcome measures in rheumatoid arthritis: conclusion. Journal of Rheumatology, 20, 590.
  • 6
    Felson DT, Anderson JJ, Boers M., et al. (1995) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis. Arthritis and Rheumatism, 36, 729740.
  • 7
    Boers M., Tugwell P., Felson DT, van Riel PLCM, Kirwan JR, Edmonds JP, Smolen JS, et al. (1994) WHO & ILAR Core Endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. Journal of Rheumatology, 21, 8689.
  • 8
    Felson DT, Anderson JJ, Boers M., et al. (1995) American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis and Rheumatism, 38, 727735.
  • 9
    Boers M., van Riel PLCM, Felson DT, Tugwell P. (1995) Assessing activity of rheumatoid arthritis. Bailliere's Clinical Rheumatology, 9, 305317.
  • 10
    Tugwell P., Pincus T., Yocum D., et al. (1995) Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. New England Journal of Medicine, 333, 137141.
  • 11
    Tugwell P., Boers M., For the OMERACT Committee. (1993) Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. Journal of Rheumatology, 20, 553556.
  • 12
    Tugwell P., Bombardier C. (1982) A methodologic framework for developing and selecting endpoints in clinical trials. Journal of Rheumatology, 9, 758762.
  • 13
    Wolfe F., Cathey MA. (1991) The assessment and prediction of functional disability in rheumatoid arthritis. Journal of Rheumatology, 18, 12981306.
  • 14
    Wolfe F., Kleinheksal SM, Cathey MA, Hawley DHJ, Spitz P. (1991) Antecedents of mortality in rheumatoid arthritis: a study of 1405 patients with rheumatoid arthritis in a community setting. Arthritis and Rheumatism, 34 (Suppl.), 48.
  • 15
    van der Heijde DMFM, van Riel PLCM, van Rijswijk MH, van de Putte LBA. (1988) Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. Arthritis and Rheumatism, 17, 284292.
  • 16
    Klinkhoff AV, Bellamy N., Bombardier C., et al. (1988) An experiment in reducing inter-observer variability in the examination for joint tenderness. Journal of Rheumatology, 15, 492494.
  • 17
    van der Heijde DMFM, van't Hof MA, van Riel PLCM, van Leeuwen MA, van Rijswijk MT, van de Putte LBA. (1992) A comparison of validity of single variables and composed indices for measuring disease activity in rheumatoid arthritis. Annals of Rheumatic Disease, 51, 177181.
  • 18
    Kazis LE, Anderson JJ, Meenan RF. (1990) Health status as a predictor of mortality in rheumatoid arthritis: a 5-year study. Journal of Rheumatology, 17, 609613.
  • 19
    Leigh JP, Fries JF. (1990) Mortality predictors among 263 patients with rheumatoid arthritis. Journal of Rheumatology, 18, 12901297.
  • 20
    Pincus T., Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. (1984) Severe functional declines, work disability, and increased mortality in 75 rheumatoid arthritis patients studied over 9 years. Arthritis and Rheumatism, 27, 864872.
  • 21
    Guyatt GH, Feeny DH, Patrick DL. (1993) Measuring health-related quality of life. Annals of Internal Medicine, 118, 622629.
  • 22
    Gotzsche PC. (1990) Sensitivity of effect variables in rheumatoid arthritis: a meta-analysis of 130 placebo-controlled NSAID trials. Journal of Clinical Epidemiology, 43, 13131318.
  • 23
    Felson DT, Anderson JJ, Meenan RF. (1990) The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of 2 meta-analyses. Arthritis and Rheumatism, 33, 14491461.
  • 24
    Bombardier C., Raboud J., and The Auranofin Cooperation Group. (1991) Comparison of health-related quality of life measures for rheumatoid arthritis research. Controlled Clinical Trials, 12 (Suppl.), 243256.
  • 25
    Anderson JJ, Chernoff MC. (1993) Sensitivity to change of rheumatoid arthritis clinical trials outcome measures. Journal of Rheumatology, 20, 535537.
  • 26
    Hawley DJ, Wolfe F. (1992) Sensitivity to change of the Health Assessment Questionnaire (HAQ) and other clinical and health status measures in RA: results of short term clinical trials and observational studies vs. long term observational studies. Arthritis Care and Research, 5, 130136.
  • 27
    Spiegel JS, Paulus HE, Ward NB, Spiegel TM, Leake B., Ranr RL. (1987) What are we measuring? An examination of walk time and grip strength. Journal of Rheumatology, 14, 8086.
  • 28
    Boers M., Tugwell P., For the OMERACT Committee. (1993) OMERACT conference questionnaire results. Journal of Rheumatology, 20, 552555.
  • 29
    Gotzsche PC, Podenphant J., Olesen M., Halberg P. (1993) Meta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefit. Journal of Clinical Epidemiology, 45, 587594.
  • 30
    Ward MM. (1994) Clinical measures in rheumatoid arthritis. Which are the most useful in assessing patients Journal of Rheumatology, 21, 1721.
  • 31
    Pinals RS, Masi AT, Larsen RA. (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis and Rheumatism, 24, 13081315.
  • 32
    Hazes JMW, Hayton R., Silman AJ. (1993) A re-evaluation of the symptom of morning stiffness. Journal of Rheumatology, 20, 11381142.
  • 33
    van Riel PLCM, van de Putte LBA. (1994) Clinical assessment and clinical trials in rheumatoid arthritis. Current Opinion in Rheumatology, 6, 132139.
  • 34
    Gotzsche PC. (1989) Meta-analysis of grip strength: most common, but superfluous variable in comparative NSAID trials. Danish Medical Bulletin, 36, 493495.
  • 35
    O'Driscoll SW, Horii E., Ness RR. (1992) The relationship between wrist position, grasp size and grip strength. Journal of Hand Surgery, 17 (Abstract), 169177.
  • 36
    Dick WC, Grayson MF, Woodburn A., Nuki G., Buchanan WW. (1970) Indices of anti-inflammatory activity. Relationship between isotope studies and clinical methods. Annals of Rheumatic Diseases, 29, 643648.
  • 37
    Gotzsche PC. (1989) Patient's preference in indomethacin trials: an overview. Lancet, i, 8891.
  • 38
    Jacoby RK, Jayson MIV, Cosh JA. (1993) Onset, early stages and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow up. British Medical Journal, 2, 96100.
  • 39
    Edmonds JP, Scott DC, Furst DE. (1993) Antirheumatic drugs: a proposed new classification. Arthritis and Rheumatism, 36, 336339.
  • 40
    Pincus T., Callahan LF. (1992) Quantitative measures to assess, monitor and predict morbidity and mortality in rheumatoid arthritis. Bailliere's Clinical Rheumatology, 6, 161191.
  • 41
    Smolen JS, Breedveld FC, Eberl G., et al. (1995) Validity and reliability of the 28-joint count for the assessment of RA activity. Arthritis and Rheumatism, 38, 3843.
  • 42
    Fuchs HA, Brooks RH, Callahan LF, Pincus T. (1989) A simplified 28-joint quantitative articular index in rheumatoid arthritis. Arthritis and Rheumatism, 32, 531537.
  • 43
    ACR Committee on Outcome Measure in Rheumatoid Arthritis Clinical Trials. (1994) Reduced joint count in rheumatoid arthritis. Arthritis and Rheumatism, 37, 463464.
  • 44
    Smolen JS. (1994) Report on the EULAR Standing Committee on International Clinical Studies including therapeutic trials. Rheumatology in Europe, 23, 3739.
  • 45
    Paimela L. (1992) The radiographic criterion in the (1987) revised criteria for rheumatoid arthritis: reassessment in a prospective study of early disease. Arthritis and Rheumatism, 35, 255258.
  • 46
    Thompson PW, Hart LE, Goldsmith CH, Spector TD, Bell MJ, Ramsden MF. (1991) Comparison of 4 articular indices for use in clinical trials in RA: patient, order and observer variation. Journal of Rheumatology, 18, 661665.
  • 47
    Bellamy N., Buchanan WW. (1993) Clinical evaluation in rheumatoid arthritis. In: Arthritis and Allied Conditions: a textbook of rheumatology, ed. McCarty DJ, pp. 151178, Lea & Febinge, Philadelphia .
  • 48
    Wagstaff S., Smith OV, Wood PHN. (1985) Verbal pain, descriptions used by patients with rheumatoid arthritis. Annals of Rheumatic Diseases, 44, 262265.
  • 49
    Carlsson AM. (1983) Assessment of chronic pain I: Aspects of the reliability and validity of the visual analogue scale. Pain, 16, 87101.
  • 50
    Bellamy N., Goldsmith CH, Buchanan WW, Campbell J., Duku E. (1991) Prior score availability observation using the WOMAC Osteoarthritis Index. British Journal of Rheumatology, 30, 150151.
  • 51
    Melzack R. (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain, 1, 277299.
  • 52
    Bombardier CL, Wares J., Russell, IJ, et al. (1986) Auranofin Therapy and quality of life in patients with rheumatoid arthritis: results of a multicentre trial. American Journal of Medicine, 81, 565578.
  • 53
    Blackburn WD. (1994) Validity of acute phase proteins as markers of disease activity. Journal of Rheumatology, 21, 913.
  • 54
    Emery P., Luqmani R. (1993) The validity of surrogate markers in rheumatic diseases. British Journal of Rheumatology, 32, 38.
  • 55
    Volakanis JE. (1993) Acute-phase proteins in rheumatic diseases. In: Arthritis and Allied Conditions: a textbook on rheumatology, ed. McCarty DJ, pp. 469477, Lea & Febinger, Philadelphia .
  • 56
    Mallya RK, Mace BEW. (1981) The assessment of disease activity in RA using a multivariate analysis. Rheumatology and Reliabilitation, 20, 1417.
  • 57
    Larsen A., Thoen J. (1987) Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year. Scandinavian Journal of Rheumatology, 16, 395401.
  • 58
    Scott DL, Panayi GS, de Riel PLCM, Smolen J., van de Putte LBA, The Consensus Study Group of the European Workshop for Rheumatology. (1992) Disease activity in rheumatoid arthritis: preliminary report. Clinical and Experimental Rheumatology, 10, 521535.
  • 59
    Wolfe F., Michaud K. (1994) The clinical and research significance of erythrocyte sedimentation rate. Journal of Rheumatology, 21, 12271237.
  • 60
    Scott DI, Symmons DPM, Coulton BC, Popert AJ. (1987) Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet, i, 11081111.
  • 61
    Gotzsche PC. (1989) Methodology and overt and hidden bias in reports of 196 double blind trials of NSAIDs in rheumatoid arthritis.. Controlled Clinical Trials, 10, 3156.
  • 62
    Kushner I. (1991) C-reactive protein in rheumatology. Arthritis and Rheumatism, 34, 10651068.
  • 63
    Brower AC. (1990) Use of the radiograph to measure the course of RA. The gold standard vs. fool's gold. Arthritis and Rheumatism, 33, 316324.
  • 64
    Paulus HE, Scott DL, Edmonds JP. (1992) Classification of antirheumatic drugs-a new proposal. Arthritis and Rheumatism, 35, 364365.
  • 65
    Alarcon GS, Lopez-Mendez A., Walter J., et al. (1992) Radiographic evidence of disease progression in metho-trexate treated and non-methotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. Journal of Rheumatology, 19, 18681873.
  • 66
    Paulus HE, Bulpitt KJ. (1991) Outcome measures. Rheumatic Clinics of North America, 21, 605618.
  • 67
    van der Heijde DMFM, van't HOFM, van Riel PLCM, van de Putte LBA. (1993) Development of a disease activity score based on judgement in clinical practice by rheumatologists. Journal of Rheumatology, 20, 579581.
  • 68
    Long AF, Scott DL (1994) Measuring health status and outcomes in rheumatoid arthritis within routine clinical practice. British Journal of Rheumatology, 33, 682685.
  • 69
    Symmons DPM, Hassell AB, Gunatillaka KAN, Jones PJ, Scholium J., Dawes PT. (1995) Development and preliminary assessment of a simple measure of overall status in rheumatoid arthritis (OSRA) for routine clinical use. Quarterly Journal of Medicine, 88, 429437.
  • 70
    van der Heijde DMFM, van't Hof MA, van Riel PLCM, et al. (1990) Judging disease-activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Annals of Rheumatic Diseases, 49, 916920.
  • 71
    Emery P. (1994) Assessment of rheumatoid arthritis-a clinician's viewpoint. Journal of Rheumatology, 21, 2024.
  • 72
    Felson DT, Anderson JJ, Meenan RF. (1990) Time for changes in the design, analysis and reporting of rheumatoid arthritis. Arthritis and Rheumatism, 33, 140149.
  • 73
    Roberts RS. (1993) Pooled outcome measures in arthritis: the pro and cons. Journal of Rheumatology, 20, 566567.
  • 74
    Tugwell P., Boers M., Baker P., Wells G., Snider J. (1994) Endpoints in rheumatoid arthritis. Journal of Rheumatology, 21, 28.
  • 75
    Boers M., Brooks PM, Tugwell P. (1995) OMERACT: state of the ‘ACT’. Journal of Rheumatology, 22, 14311432.
  • 76
    Weinblatt ME, Kaplan H., Germain BF, et al. (1990) Low-dose methotrexate compared to auranofin in adult rheumatoid arthritis: a 36-week, double-blind trial. Arthritis and Rheumatism, 33, 330338.
  • 77
    van der Heide A., Jacobs JWG, Schenk Y., Bijlsma WJ. (1994) Endpoints measures in rheumatoid arthritis: group summary and individual patient analysis. Journal of Rheumatology, 21, 21952199.
  • 78
    Meenan RF, Pincus T. (1987) The status of patient status measures. Journal of Rheumatology, 14, 411414.
  • 79
    Bowling A. (1991) Measuring health. A review of quality of life measurement scales. Open University Press, Milton Keynes .
  • 80
    Hornquist JO. (1989) Quality of life: concept and assessment. Scandinavian Journal of Social Medicine, 18, 6979.
  • 81
    World Health Organisation (1958) The First Ten years of World Health Organisation. WHO, Geneva .
  • 82
    Wolfe F., Kleinheksel S., Cathey M., Hawley DJ, Spitz PW, Fries JF. (1988) The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. Journal of Rheumatology, 15, 14801488.
  • 83
    Deyo RA. (1994) The quality of life, research and care. Annals of Internal Medicine, 114, 695697.
  • 84
    Bell MJ, Bombardier C., Tugwell P. (1990) Measurement of functional status, quality of life and utility in rheumatoid arthritis. Arthritis and Rheumatism, 33, 591601.
  • 85
    van der Linden J., Boers M. (1995) A framework to classify burden of illness measures. Journal of Rheumatology, 22, 11851187.
  • 86
    Patrick DL, Deyo RA. (1989) Generic and diseasespecific measures in assessing health status and quality of life. Medical Care, 27, 217232.
  • 87
    Guyatt G. (1995) A taxonomy of health status instruments. Journal of Rheumatology, 22, 11881190.
  • 88
    Fitzpatrick R., Ziebland S., Jenkinson C., Mowat A., Mowat A. (1993) A comparison of the sensitivity to change of several health status instruments in rheumatoid arthritis. Journal of Rheumatology, 20, 429436.
  • 89
    van Dam FSAM, Somers R., van Beek-Couzijn AL. (1981) Quality of life: some theoretical issues. Journal of Clinical Pharmacology, 21, 166168.
  • 90
    Kurd P., Carr-Hill R. (1987) The Nottingham Health Profile: a useful tool for epidemiologist Social Science and Medicine, 25, 905910.
  • 91
    van Riel PLCM, van Lankveld WCJM. (1993) Quality of life III. Rheumatoid arthritis. Pharmacy World and Science, 15, 9397.
  • 92
    Bendtsen P., Akerlind I., Hornquist JO. (1990) Assessment of quality of life in rheumatoid arthritis–methods and implications. Pharmacoeconomics, 5, 286298.
  • 93
    Kirschner B., Guyatt G. (1985) A methodological framework for assessing health indices. Journal of Chronic Diseases, 38, 2736.
  • 94
    Liang MH, Cullen KE, Larson MG. (1983) Measuring functional status in rheumatic diseases clinical trials. Clinics in Rheumatic Diseases, 9, 531539.
  • 95
    Fries JF, Spitz PW, Kraines RG, Holman HR. (1980) Measurement of patient outcome in arthritis. Arthritis and Rheumatism, 23, 137145.
  • 96
    Bombardier A., Tugwell P. (1987) Methodological considerations in functional assessment. Journal of Rheumatology, 14, 610.
  • 97
    Meenan RF, Gertman PM, Mason JH. (1980) Measuring health status in arthritis–the Arthritis Impact Measurement Scales. Arthritis and Rheumatism, 23, 146150.
  • 98
    Pincus T., Summey JA, Soraci SAJR, Wallston KA, Hummon NP. (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis and Rheumatism, 26, 13461353.
  • 99
    Tugwell P., Bombardier C., Buchanan WW, Goldsmith CH, Grace E., Hanna B. (1987) The MACTAR Patient Preference Disability: an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. Journal of Rheumatology, 14, 446451.
  • 100
    Bellamy N. (1991) Prognosis in rheumatoid arthritis. Journal of Rheumatology, 18, 12771279.
  • 101
    Wolfe F., Pincus T. (1991) Standard self-report questionnaires in routine clinical and research practice—an opportunity for patients and rheumatologists. Journal of Rheumatology, 18, 643646.
  • 102
    Fries JF, Spitz PW, Young DY. (1982) The dimensions of health outcome: the Health Assessment Questionnaire, disability and pain scales. Journal of Rheumatology, 9, 789793.
  • 103
    Ramey DR, Raynauld JP, Fries JF. (1992) The Health Assessment Questionnaire 1992. Status and review. Arthritis Care and Research, 5, 119129.
  • 104
    Meenan RF, Gertman PM, Mason JH, Dunàif R. (1982) The AIMS-further investigations of a health status measure. Arthritis and Rheumatism, 25, 10481053.
  • 105
    Anderson JJ, Firschein HE, Meenan RF. (1989) Sensitivity of a health status measure to short term clinical changes in activity. Arthritis and Rheumatism, 32, 844850.
  • 106
    Liang MH, Lawson MG, Cullen KE, Schwartz JA. (1985) Comparative measurement efficacy and sensitivity of five health status instruments for arthritis research. Arthritis and Rheumatism, 28, 542547.
  • 107
    Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. (1992) AIMS2. The content and properties of a revised and expanded AIMS health status questionnaire. Arthritis and Rheumatism, 35, 110.
  • 108
    Berkanovic E., Hurwicz ML. (1990) Rheumatoid arthritis and comorbidity. Journal of Rheumatology, 17, 888892.
  • 109
    Hughes SL, Edelman P., Chang RW, Singer RH, Schuette P. (1991) The GERI-AIMS: reliability and validity of the AIMS adapted for elderly respondents. Arthritis and Rheumatism, 34, 856865.
  • 110
    Tugwell P., Bombardier C., Buchanan WW, et al. (1990) Methotrexate in rheumatoid arthritis: impact on quality of life assessed by traditional standard item and individualized patient preference health status questionnaire. Archives of Internal Medicine, 150, 5962.
  • 111
    Chambers LW, MacDonald LA, Tugwell P., Buchanan WW, Kraag G. (1982) The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease. Journal of Rheumatology, 9, 780784.
  • 112
    Kaplan RM, Bush JW, Berry CC. (1976) Health status: types of validity and the index of well-being. Health Services Research, 11, 478507.
  • 113
    Carter WB, Bobbitt RA, Bergner M., Gilson BS. (1976) Validation of an internal scaling: the Sickness Impact Profile. Health Services Research, 11, 516527.
  • 114
    Hunt S., McKenna S., McEwen J., Williams J., Papp E. (1981) The Nottingham Health Profile: subjective health status and medical consultation. Social Science and Medicine, 15 (Abstract), 221229.
  • 115
    van Leeuwen MA, van der Heijde DMFM, van Rijswijk MH, et al. (1994) Inter-relationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts and acute phase reactants. Journal of Rheumatology, 21, 425429.
  • 116
    Buchbinder R., Bombardier C., Yeung M., Tugwell P. (1995) Which outcome measures should be used in rheumatoid arthritis clinical trials Arthritis and Rheumatism, 38, 15681580.
  • 117
    Thompson PW, Kirwan JR. (1995) Joint counts: A review of old and new articular indices of joint inflammation. British Journal of Rheumatology, 34, 10031008.
  • 118
    Anon. (1988) Guidelines for the clinical evaluation of anti-inflammatory and antirheumatic drugs (adults and children), pp. 135. US Department of Health and Human Services, Public Health Services, Food and Drug Administration, Washington .
  • 119
    Guyatt GH, van Zanten SJOV, Feeny Dh, Patrick DL. (1989) Measuring quality of life in clinical trials: a taxonomy and review. Canadian Medical Association Journal, 140, 14411448.